News
Media
PodcastsCase Based Peer PerspectivesInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Frank McGillin

Advertisement

Articles by Frank McGillin

Why specialty care outcomes depend on virtual access to expertise

ByFrank McGillin
January 27th 2022

Difficulties accessing virtual care and support remain a barrier to the best care for patients facing complex conditions.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contemporary OB/GYN

    1

    Contemporary OB/GYN week in review: FemVue clearance, flibanserin approval, and more

    2

    FDA clears FemVue Controlled for in-office tubal assessment

    3

    Objective blood loss measures reveal higher postpartum hemorrhage rates

    4

    GSK, Spero Therapeutics resubmits NDA for tebipenem HBr as oral option for complicated urinary tract infections

    5

    Restrictive abortion laws linked to increased EMTALA violations

    • Advertise
    • Contact Us
    • Job Board
    • Terms of Use
    • Privacy Policy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us